- Market Capitalization, $K 37,401,636
- Shares Outstanding, K 493,100
- Annual Sales, $ 8,717 M
- Annual Income, $ 335,000 K
- 60-Month Beta 0.90
- Price/Sales 4.29
- Price/Cash Flow 16.75
- Price/Book 1.86
|Period||Period Low||Period High||Performance|
| || |
-1.11 (-1.49%)since 11/03/23
| || |
-9.28 (-11.25%)since 09/01/23
| || |
+3.11 (+4.44%)since 12/02/22
Is Swiss eye care leader Alcon Inc. (ALC) a buy, hold, or sell after its third-quarter earnings release yesterday? Let’s look at its financial metrics to gauge its prospects… Geneva, Switzerland-based...
EQNX::TICKER_START (NASDAQ:OKYO),(NYSE:ALC),(NYSE:BLCO),(NYSE:JNJ),(OTCQX:RHHBY) EQNX::TICKER_END
September S&P 500 futures (ESU23) are down -0.61%, and September Nasdaq 100 E-Mini futures (NQU23) are down -0.48% this morning as market participants digested the latest U.K. employment data, which fueled...
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced results from a new study presented at the American Society of Cataract and Refractive Surgery...
Alcon Inc. (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of all proposed resolutions at its 2023 Annual General Meeting (AGM)....
The Board of Directors (the “Board”) of Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED) (the “Company” or “MindMed”), a clinical stage biopharmaceutical company developing novel product...
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, will once again have the largest surgical ophthalmic presence at the American Society of Cataract and Refractive...
Amid persistent supply-chain headwinds, Alcon's (ALC) first-quarter top-line results are likely to reflect the commercial execution of new product launches across its segments and contributions from strategic...
ALC vs. EW: Which Stock Is the Better Value Option?
Philips (PHG) announces its expansion with MIT IMES, which will help researchers and educators access a new critical care dataset.
|Franklin Switzerland ETF|
|Switzerland Ishares MSCI ETF|
|Legg Clearbridge Large Cap Groowth ETF|
|Knowledge Leaders Developed World ETF|
|Legg Clearbridge All Cap Growth ETF|
|3rd Resistance Point||75.50|
|2nd Resistance Point||74.72|
|1st Resistance Point||73.97|
|1st Support Level||72.44|
|2nd Support Level||71.66|
|3rd Support Level||70.91|